RD06-04

DB24647InvestigationalCell transplant therapies

RD06-04 is a biologic drug. RD06-04 is under investigation in clinical trial NCT06986018 (Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and...

Mechanism: Pharmacologically active on B-lymphocyte antigen CD19
Curator reviewed
Code names: RD06-04 · RD06-04 cell · RD06-04 Cells

Resolves to

Targets

P15391CD19

What you can answer from here — as of June 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with RD06-04, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account